Supplementeray table II- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al

Published: 9 May 2022| Version 1 | DOI: 10.17632/5jy3c6jrrr.1
Contributor:
Julia Vanlerberghe

Description

Supplementary table II : number and reasons of JAK inhibitor discontinuation

Files

Institutions

Universite de Lille

Categories

Descriptive Table

Licence